Today, Canabo Medical Inc. (TSX-V:CMM) (OTCQB:CAMDF) released the results of a new, landmark observational study that connects doctor-supervised medical cannabis treatments to a sharp drop in benzodiazepine reliance among Canadian patients.

Research conducted over the past year revealed that 40 per cent of patients who were prescribed medical cannabis to treat pain and anxiety eliminated the use of benzodiazepines within 90 days. That percentage increased to 45 per cent within a year of cannabis treatment. The findings were announced by Dr. Neil Smith during a presentation at the Canadian Consortium for the Investigation of Cannabinoids (CCIC) event in Toronto.

I will be looking at a recent research report by Chris Damas, an analyst at BCMI Research. Damas goes into detail about some of the key fundamentals relating to supply and demand with respect to marijuana companies that he believes are sure to lead to massive declines in stock prices sooner rather than later.

New IPOs have resulted in large-scale venture capital

America's neighbor to the north is fast moving toward legalizing recreational marijuana nationwide, which would make Canada the second country in the world to do so. And the impact of having weed legalized on such a big scale, so close to home, may affect the future of pot in the United States.

When Hadley Ford created a company for investing in the fast-growing business of legal marijuana, the former Goldman Sachs Group Inc. investment banker left New York and headed north of the border.

While more than half of U.S. states allow marijuana for medical or recreational use, the drug is still outlawed by the federal government, starving pot entrepreneurs of institutional capital. Major stock exchanges won’t accept listings for businesses that Washington deems illegal, and banks and other lenders have stayed mostly on the sidelines.

Remedy Ice Cream is made in Calgary and infused with shatter — a concentrated form of marijuana.

The operation may not be legal but it's not exactly underground, either.

Co-founder Chris Vasconcellos says the ice cream is meant for licensed medical marijuana patients only. As a licensed user himself, he said he was looking for a different way to consume his medicine, which led him to the idea.

He doesn't have a licence to sell the drug, however, so he's wary of law enforcement — but still willing to talk publicly about what he does.

He's created a widespread online presence and has been making the rounds on pot-themed podcasts, promoting the product as a first of its kind in Canada.

Marijuana activist Dana Larsen is making another tour stop in Calgary a year after he was arrested for giving away cannabis seeds.

The Vancouver-based cannabis legalization advocate admits he is “a little nervous” about coming back to the city where he was charged with one count of trafficking marijuana and one count of possession for the purpose of trafficking.

The Liberal government's point man on pot says Canada Day 2018 should not be about legalizing marijuana but about recognizing the country's history.

Bill Blair, the parliamentary secretary to Justice Minister Jody Wilson-Raybould, said Wednesday he's a proud Canadian who believes July 1 is a day to celebrate the country's birth "for that reason and that reason alone."

"I believe that ... a reasonable goal is to have all this work done by the beginning of July, but by that date and on that date are very different things," Blair said in an interview.

"I don't think that's an appropriate date. That's my opinion."

What’s the number one long-term threat to Canada’s Marijuana Stocks?

Competition. There, I said it.

Canadian marijuana companies such as Canopy Growth Corp. (TSX:WEED), Aphria Inc. (TSX:APH), and Aurora Cannabis Inc. (TSXV:ACB) are each making a concerted effort to come out as the top dog in global cannabis production. Will they? Or will large multinational players, consolidation, and global competition make the current situation a dire one for Canadian marijuana producers in only a short few years?

Foresight is godly, and hindsight is 20/20, but in the current environment for cannabis companies, it seems that perspective is hard to come by. Let’s put the facts into perspective.

Fact #1:…

Medical marijuana producer Aphria Inc. is expanding into the lucrative U.S. market with an initial $25 million investment to set up shop in Florida, which recently legalized pot for medical use.

The foray is its first major step in a U.S. expansion strategy through a series of transactions. The result will be a new company called Liberty Health Sciences Inc., a subsidiary of Canadian Securities Exchange-listed SecureCom Mobile Inc. that will acquire Chestnut Hill Tree Farm, which is one of the seven companies licensed in Florida to dispense marijuana to patients.

At least three provinces are making it clear they expect Ottawa to foot the bill for costs associated with its plan to legalize marijuana — an issue that will have significant impacts in their jurisdictions.

In Edmonton on Wednesday, Alberta Justice Minister Kathleen Ganley said there likely be additional financial pressures related to regulation, testing and sharing public information about a legalized regime.

“We certainly are expecting some help with that — in what form that comes is difficult to say without having seen the regulations,” she said.

The government is expected to introduce legislation as soon as next week, ahead of annual “Weed Day” celebrations on April 20, to regulate the use of marijuana.